Clinical Trial Update: Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Erlotinib with standard platinum-based chemotherapy for newly diagnosed advanced non-small cell lung cancer; the study was terminated a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: TERMINATED | Results posted: 2015-08-17